Chelsea Lynn Daigle, OTR/L | |
1 Emile Levasseur Dr, Sanford, ME 04073 | |
(207) 324-4942 | |
Not Available |
Full Name | Chelsea Lynn Daigle |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 1 Emile Levasseur Dr, Sanford, Maine |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821741018 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2081S0010X | Physical Medicine & Rehabilitation - Sports Medicine | OT4158 (Maine) | Secondary |
225X00000X | Occupational Therapist | OT4158 (Maine) | Primary |
Mailing Address | Practice Location Address |
---|---|
Chelsea Lynn Daigle, OTR/L 1 Emile Levasseur Dr, Sanford, ME 04073 Ph: (207) 324-4942 | Chelsea Lynn Daigle, OTR/L 1 Emile Levasseur Dr, Sanford, ME 04073 Ph: (207) 324-4942 |
News Archive
Experts from 28 of the nation's leading health systems developed a comprehensive financial modeling tool to assess the economic impact associated with a system-wide transition to accountable care.
Rehabilitation programs must become an integral part of cardiac care to significantly reduce the burden of living with heart disease, one of the most common chronic diseases and causes of death globally, according to York University Professor Sherry Grace.
A new study of nearly 70,000 women found a clear association between abuse in childhood and adolescence and the risk of type 2 diabetes in adult women.
SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Harvard-affiliated Brigham and Women's Hospital in Boston has performed New England's first implant of the SynCardia temporary Total Artificial Heart.
Men with a severe form of a sleep breathing disorder called obstructive sleep apnoeahypopnoea have an increased risk of fatal and non-fatal cardiovascular events, concludes a study published in this week's issue of The Lancet.
› Verified 8 days ago